Re-envisioning the supply chain to deliver transparent, game-changing value

Drivers for Change and Innovation

Traditional bulk purchasing of commercial clinical supply* is time consuming, inefficient, expensive and carries risk. Moreover, access to medicines, especially limited distribution drugs, has become increasingly complex and waste, overage or expired products continue to be a problem. Lastly, there has been an increase in the need for virtual or decentralized solutions as the industry continues to focus on patient-centric solutions.

 

SupplyRx Solutions

SupplyRx innovation eliminates conventional supply chain processes and waste, reduces costs and provides virtual, secure and efficient direct-to-patient solutions.

 

Bulk Purchasing
VS.
Screen Shot 2022-02-02 at 4.27.10 PM.png
Dispense to Patient*
SupplyRx Innovation
Screen Shot 2022-02-02 at 4.28.06 PM.png
Dispense to Patient*

* Commercial clinical supply = Any FDA (NDC) or Canadian (DIN) approved medicine or supply used in any phase study